1.Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale
Pil Hyung LEE ; Jung-Sun KIM ; Jae-Kwan SONG ; Sun U. KWON ; Bum Joon KIM ; Ji Sung LEE ; Byung Joo SUN ; Jong Shin WOO ; Soe Hee ANN ; Jung-Won SUH ; Jun Yup KIM ; Kyusup LEE ; Sang Yeub LEE ; Ran HEO ; Soo JEONG ; Jeong Yoon JANG ; Jang-Whan BAE ; Young Dae KIM ; Sung Hyuk HEO ; Jong S. KIM
Journal of Stroke 2024;26(2):242-251
Background:
and Purpose In young patients (aged 18–60 years) with patent foramen ovale (PFO)- associated stroke, percutaneous closure has been found to be useful for preventing recurrent ischemic stroke or transient ischemic attack (TIA). However, it remains unknown whether PFO closure is also beneficial in older patients.
Methods:
Patients aged ≥60 years who had a cryptogenic stroke and PFO from ten hospitals in South Korea were included. The effect of PFO closure plus medical therapy over medical therapy alone was assessed by a propensity-score matching method in the overall cohort and in those with a high-risk PFO, characterized by the presence of an atrial septal aneurysm or a large shunt.
Results:
Out of the 437 patients (mean age, 68.1), 303 (69%) had a high-risk PFO and 161 (37%) patients underwent PFO closure. Over a median follow-up of 3.9 years, recurrent ischemic stroke or TIA developed in 64 (14.6%) patients. In the propensity score-matched cohort of the overall patients (130 pairs), PFO closure was associated with a significantly lower risk of a composite of ischemic stroke or TIA (hazard ratio [HR]: 0.45; 95% confidence interval [CI]: 0.24–0.84; P=0.012), but not for ischemic stroke. In a subgroup analysis of confined to the high-risk PFO patients (116 pairs), PFO closure was associated with significantly lower risks of both the composite of ischemic stroke or TIA (HR: 0.40; 95% CI: 0.21–0.77; P=0.006) and ischemic stroke (HR: 0.47; 95% CI: 0.23–0.95; P=0.035).
Conclusion
Elderly patients with cryptogenic stroke and PFO have a high recurrence rate of ischemic stroke or TIA, which may be significantly reduced by device closure.
3.Treatment options for isolated iliac artery aneurysms and their impact on aortic diameter after treatment
Jang Yong KIM ; Dae Hwan KIM ; Cheng QUAN ; Young Ju SUH ; Hyun Young ANN ; Ji Il KIM ; In Sung MOON ; Taeseung LEE
Annals of Surgical Treatment and Research 2019;96(3):146-151
PURPOSE: Isolated iliac artery aneurysm (IIAA) is uncommon. It is frequently treated by endovascular aneurysm repair (EVAR). This study was to evaluate treatment results of IIAA and survey aortic diameter after EVAR. METHODS: Patients treated for IIAA in Seoul St. Mary's Hospital and Bundang Seoul National University from 2005 to April 2016 were retrospectively enrolled. The inclusion criteria of IIAA was >30 mm of iliac artery aneurysm without abdominal aortic aneurysm, which was treated by open surgical repair (OSR) or EVAR. Patients' clinical characteristics, treatment results, and mortality were obtained from electronic medical records. Diameters of aorta and iliac arteries were measured periodically with scheduled interval based on CT scans. RESULTS: Forty-nine patients (40 males; mean age, 71.9 ± 11.1 years) were enrolled. Five ruptured IIAAs were treated with EVAR (n = 1) or hybrid methods (n = 4). The diameter of ruptured IIAAs was 65 ± 31.4 mm, which was not significantly different from that of elective (44.3 ± 17.0 mm). Forty-four elective IIAA underwent 9 OSR, 31 EVARs, and 3 hybrid treatments (15 bifurcated and 12 straight stent-grafts). Treatment success rate was 93.8% without hospital mortality. There were 4 type I endoleak, 1 type II endoleak, and 1 type III endoleak without aneurysm-related mortality during follow-up. However, the aortic diameter was increased over time though there was no change or decrease in common iliac artery's diameter. CONCLUSION: Treatment of IIAA included various endovascular modalities as well as open surgery. Regular surveillance is still needed due to aortic dilatation after its treatment.
Aneurysm
;
Aorta
;
Aortic Aneurysm, Abdominal
;
Dilatation
;
Electronic Health Records
;
Endoleak
;
Endovascular Procedures
;
Follow-Up Studies
;
Hospital Mortality
;
Humans
;
Iliac Aneurysm
;
Iliac Artery
;
Male
;
Mortality
;
Retrospective Studies
;
Seoul
;
Tomography, X-Ray Computed
4.Characteristics of Faecal Microbiota in Korean Patients with Clostridioides difficile-associated Diarrhea
Yong Duk JEON ; Hea Won ANN ; Woon Ji LEE ; Jun Hyoung KIM ; Hye SEONG ; Jung Ho KIM ; Jin Young AHN ; Su Jin JEONG ; Nam Su KU ; Joon Sup YEOM ; Dongeun YONG ; Kyungwon LEE ; Jun Yong CHOI
Infection and Chemotherapy 2019;51(4):365-375
BACKGROUND:
The intestinal microbiota plays an important role in the pathogenesis of Clostridioides difficile-associated diarrhea, and regional and racial characteristics influence the microbiome composition and diversity. We investigated the intestinal microbiome characteristics of patients with C. difficile colitis (CD+) compared to those of patients with colitis not due to C. difficile (CD−), patients with vancomycin-resistant enterococci (VRE) colonization, and healthy controls, in Korea.
MATERIALS AND METHODS:
We collected stool samples from 24, 18, 11 and 13 subjects within CD+, CD−, VRE and healthy control groups, respectively. The microbial communities were evaluated by 454-pyrosequencing of bacterial 16s rRNA.
RESULTS:
The species richness and microbial diversity were significantly lower in the CD+ group compared to those in healthy controls, but not compared to those in CD− and VRE groups. Phylum-level analysis showed that the proportion of Actinobacteria in the CD+ group was significantly lower than in the healthy control, but was unchanged compared to that in CD− and VRE groups. At the genus level, compared to the healthy group, the CD+ group showed significantly lower proportions of Blautia, Bifidobacterium, Faecalibacterium et al. Compared to the VRE group, the CD+ group showed a significantly higher proportion of Anaerostipes.
CONCLUSIONS
We could identify the intestinal microbiome characteristics of Koreans with C. difficile colitis. It might help to develop microbiome based diagnostic and treatment modalities.
5.Long Pentraxin 3 as a Predictive Marker of Mortality in Severe Septic Patients Who Received Successful Early Goal-Directed Therapy.
Sun Bean KIM ; Kyoung Hwa LEE ; Ji Un LEE ; Hea Won ANN ; Jin Young AHN ; Yong Duk JEON ; Jung Ho KIM ; Nam Su KU ; Sang Hoon HAN ; Jun Yong CHOI ; Young Goo SONG ; June Myung KIM
Yonsei Medical Journal 2017;58(2):370-379
PURPOSE: Pentraxin 3 (PTX3) has been suggested to be a prognostic marker of mortality in severe sepsis. Currently, there are limited data on biomarkers including PTX3 that can be used to predict mortality in severe sepsis patients who have undergone successful initial resuscitation through early goal-directed therapy (EGDT). MATERIALS AND METHODS: A prospective cohort study was conducted among 83 severe sepsis patients with fulfillment of all EGDT components and the achievement of final goal. Plasma PTX3 levels were measured by sandwich ELISA on hospital day (HD) 0, 3, and 7. The data for procalcitonin, C-reactive protein and delta neutrophil index were collected by electric medical record. The primary outcome was 28-day all-cause mortality. RESULTS: 28-day all-cause mortality was 19.3% and the median (interquartile range) APHCH II score of total patients was 16 (13–19). The non-survivors (n=16) had significantly higher PTX3 level at HD 0 [201.4 (56.9–268.6) ng/mL vs. 36.5 (13.7–145.3) ng/mL, p=0.008]. PTX3 had largest AUC(ROC) value for the prediction of mortality among PTX3, procalcitonin, delta neutrophil index, CRP and APACHE II/SOFA sore at HD 0 [0.819, 95% confidence interval (CI) 0.677–0.961, p=0.008]. The most valid cut-off level of PTX3 at HD 0 was 140.28 ng/mL (sensitivity 66.7%, specificity 73.8%). The PTX3 and procalcitonin at HD 0 showed strong correlation (r=0.675, p<0.001). However, PTX3 at HD 0 was the only independent predictive marker in Cox's proportional hazards model (≥140 ng/mL; hazard rate 7.16, 95% CI 2.46–15.85, p=0.001). CONCLUSION: PTX3 at HD 0 could be a powerful predictive biomarker of 28-day all-cause mortality in severe septic patients who have undergone successful EGDT.
APACHE
;
Biomarkers
;
C-Reactive Protein
;
Cohort Studies
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Medical Records
;
Mortality*
;
Neutrophils
;
Plasma
;
Proportional Hazards Models
;
Prospective Studies
;
Resuscitation
;
Sensitivity and Specificity
;
Sepsis
6.Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy.
Jeong Sun SEO ; Seungbok LEE ; Jong Yeon SHIN ; Yu Jin HWANG ; Hyesun CHO ; Seong Keun YOO ; Yunha KIM ; Sungsu LIM ; Yun Kyung KIM ; Eun Mi HWANG ; Su Hyun KIM ; Chong Hyun KIM ; Seung Jae HYEON ; Ji Young YUN ; Jihye KIM ; Yona KIM ; Victor E ALVAREZ ; Thor D STEIN ; Junghee LEE ; Dong Jin KIM ; Jong Il KIM ; Neil W KOWALL ; Hoon RYU ; Ann C MCKEE
Experimental & Molecular Medicine 2017;49(5):e333-
Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder that is associated with repetitive head injury and has distinctive neuropathological features that differentiate this disease from other neurodegenerative diseases. Intraneuronal tau aggregates, although they occur in different patterns, are diagnostic neuropathological features of CTE, but the precise mechanism of tauopathy is not known in CTE. We performed whole RNA sequencing analysis of post-mortem brain tissue from patients with CTE and compared the results to normal controls to determine the transcriptome signature changes associated with CTE. The results showed that the genes related to the MAP kinase and calcium-signaling pathways were significantly downregulated in CTE. The altered expression of protein phosphatases (PPs) in these networks further suggested that the tauopathy observed in CTE involves common pathological mechanisms similar to Alzheimer's disease (AD). Using cell lines and animal models, we also showed that reduced PPP3CA/PP2B phosphatase activity is directly associated with increases in phosphorylated (p)-tau proteins. These findings provide important insights into PP-dependent neurodegeneration and may lead to novel therapeutic approaches to reduce the tauopathy associated with CTE.
Alzheimer Disease
;
Brain
;
Brain Injury, Chronic*
;
Cell Line
;
Craniocerebral Trauma
;
Gene Expression Profiling*
;
Humans
;
Models, Animal
;
Neurodegenerative Diseases
;
Phosphoprotein Phosphatases
;
Phosphotransferases
;
Sequence Analysis, RNA
;
Tauopathies*
;
Transcriptome*
7.Fecal Transplantation using a Nasoenteric Tube during an Initial Episode of Severe Clostridium difficile Infection.
Yong Duk JEON ; Namki HONG ; Jung Ho KIM ; Se Hee PARK ; Sung Bae KIM ; In Ji SONG ; Hea Won ANN ; Jin Young AHN ; Sun Bean KIM ; Nam Su KU ; Kyungwon LEE ; Dongeun YONG ; June Myung KIM ; Jun Yong CHOI
Infection and Chemotherapy 2016;48(1):31-35
The incidence of Clostridium difficile infection is increasing worldwide, and its severity and resulting mortality are also on the rise. Metronidazole and oral vancomycin remain the treatments of choice, but there are concerns about treatment failure and the appearance of resistant strains. Furthermore, antibiotic therapy results in recurrence rates of at least 20%. Fecal transplantation may be a feasible treatment option for recurrent C. difficile infection; moreover, it may be an early treatment option for severe C. difficile infection. We report a case of severe C. difficile infection treated with fecal transplantation using a nasoenteric tube during an initial episode. This is the first reported case of fecal transplantation using a nasoenteric tube during an initial episode of C. difficile infection in Korea.
Clostridium difficile*
;
Clostridium*
;
Incidence
;
Korea
;
Metronidazole
;
Mortality
;
Recurrence
;
Treatment Failure
;
Vancomycin
8.Lack of associations between tumor necrosis factor-alpha genetic polymorphism -308G/A and antituberculous drug-induced maculopapular eruption.
Won Yong SUH ; Yo Han KIM ; Hyun Don JOO ; Seong Jun PARK ; Sung Hyeok RYUO ; Ji Sung CHOI ; Sun Young ANN ; Chang Hyun PARK ; Sang Hoon KIM ; Sang Heon KIM ; Young Koo JEE
Allergy, Asthma & Respiratory Disease 2015;3(2):124-127
PURPOSE: Adverse cutaneous reactions to antituberculous drugs (ATD), such as maculopapular eruption (MPE), are the most common causes of discontinuation of scheduled treatment of tuberculosis. We previously reported that tumor necrosis factor (TNF)-alpha genetic polymorphism -308G/A is significantly associated with ATD-induced hepatitis. This study aimed to investigate associations between TNF-alpha -308G/A and ATD-induced MPE. METHODS: Patients with ATD-induced MPE and controls without any adverse reactions to ATD were recruited from the database of the Adverse Drug Reaction Pharmacogenomic Research Group database of Korea. We compared the genotype frequency of TNF-alpha-308G/A between patients with ATD-induced MPE and ATD-tolerant controls. RESULTS: A total of 69 patients with ATD-induced MPE and 229 control subjects were enrolled for this study. There were no significant differences in genotype frequency between the patients and the controls, suggesting lack of associations between TNF-alpha-308G/A and ATD-induced MPE. CONCLUSION: The TNF-alpha genetic polymorphism -308G/A may not be related to the development of ATD-induced MPE, in contrast to ATD-induced hepatitis. These findings suggest that associations between TNF-alpha-308G/A and ATD-induced adverse reactions can be phenotype-specific.
Antitubercular Agents
;
Drug Eruptions
;
Drug-Related Side Effects and Adverse Reactions
;
Genotype
;
Hepatitis
;
Humans
;
Korea
;
Polymorphism, Genetic*
;
Tuberculosis
;
Tumor Necrosis Factor-alpha*
9.Practice guideline for the performance of breast ultrasound elastography.
Su Hyun LEE ; Jung Min CHANG ; Nariya CHO ; Hye Ryoung KOO ; Ann YI ; Seung Ja KIM ; Ji Hyun YOUK ; Eun Ju SON ; Seon Hyeong CHOI ; Shin Ho KOOK ; Jin CHUNG ; Eun Suk CHA ; Jeong Seon PARK ; Hae Kyoung JUNG ; Kyung Hee KO ; Hye Young CHOI ; Eun Bi RYU ; Woo Kyung MOON
Ultrasonography 2014;33(1):3-10
Ultrasound (US) elastography is a valuable imaging technique for tissue characterization. Two main types of elastography, strain and shear-wave, are commonly used to image breast tissue. The use of elastography is expected to increase, particularly with the increased use of US for breast screening. Recently, the US elastographic features of breast masses have been incorporated into the 2nd edition of the Breast Imaging Reporting and Data System (BI-RADS) US lexicon as associated findings. This review suggests practical guidelines for breast US elastography in consensus with the Korean Breast Elastography Study Group, which was formed in August 2013 to perform a multicenter prospective study on the use of elastography for US breast screening. This article is focused on the role of elastography in combination with B-mode US for the evaluation of breast masses. Practical tips for adequate data acquisition and the interpretation of elastography results are also presented.
Breast*
;
Consensus
;
Elasticity Imaging Techniques*
;
Information Systems
;
Mass Screening
;
Ultrasonography*
10.Vitrification of mouse embryos using the thin plastic strip method.
Eun Kyung RYU ; Yong Soo HUR ; Ji Young ANN ; Ja Young MAENG ; Miji PARK ; Jeong Hyun PARK ; Jung YOON ; San Hyun YOON ; Chang Young HUR ; Won Don LEE ; Jin Ho LIM
Clinical and Experimental Reproductive Medicine 2012;39(4):153-160
OBJECTIVE: The aim of this study was to compare vitrification optimization of mouse embryos using electron microscopy (EM) grid, cryotop, and thin plastic strip (TPS) containers by evaluating developmental competence and apoptosis rates. METHODS: Mouse embryos were obtained from superovulated mice. Mouse cleavage-stage, expanded, hatching-stage, and hatched-stage embryos were cryopreserved in EM grid, cryotop, and TPS containers by vitrification in 15% ethylene glycol, 15% dimethylsulfoxide, 10 microg/mL Ficoll, and 0.65 M sucrose, and 20% serum substitute supplement (SSS) with basal medium, respectively. For the three groups in which the embryos were thawed in the EM grid, cryotop, and TPS containers, the thawing solution consisted of 0.25 M sucrose, 0.125 M sucrose, and 20% SSS with basal medium, respectively. Rates of survival, re-expansion, reaching the hatched stage, and apoptosis after thawing were compared among the three groups. RESULTS: Developmental competence after thawing of vitrified expanded and hatching-stage blastocysts using cryotop and TPS methods were significantly higher than survival using the EM grid (p<0.05). Also, apoptosis positive nuclei rates after thawing of vitrified expanded blastocysts using cryotop and TPS were significantly lower than when using the EM grid (p<0.05). CONCLUSION: The TPS vitrification method has the advantages of achieving a high developmental ability and effective preservation.
Animals
;
Apoptosis
;
Blastocyst
;
Dimethyl Sulfoxide
;
Embryonic Structures
;
Ethylene Glycol
;
Ethylenes
;
Ficoll
;
Mental Competency
;
Mice
;
Microscopy, Electron
;
Plastics
;
Sucrose
;
Vitrification

Result Analysis
Print
Save
E-mail